Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Sep 17,2015
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
The Zhejiang Overseas Senior-Level Organization was founded in Feb 2011 by entrepreneur and the scientists.  The organization currently has about 1,000 members from "Thousand People
More
Dr. Chunlin Chen will participate the Zhejiang Overseas Senior-Level Biomedical Annual Meeting
Jul 30,2015
Preclinical CRO - Medicilon
Medicilon (stock code: 688202. SH) is a drug research and development outsourcing service company (CRO). Pharmacology, pharmacokinetics, and toxicology evaluation are comprehensive technical service platforms that meet international standards.
More
Preclinical CRO - Medicilon
Jun 11,2015
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Suzhou NeuPharma Co., Ltd announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.  RX108 is a novel small-molecule inhibitor
More
Medicilon congratulate NeuPharma's New Drug to initiate the first-in-human Phase I Clinical Trial
Jun 09,2015
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Dr. Chunlin Chen, Medicilon's CEO, was the host of the seminar in Tokyo and Osaka and gave a wonderful speech with the topic "Current Pharmaceutical
More
Medicilon successfully held a seminar in Tokyo and Osaka, Japan from June 3-4
Mar 31,2015
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea
On March 18, Medicilon hosted a CFDA IND seminar with Korea Pharmaceutical Manufacturers Association (KPMA) in Seoul, South Korea.  The seminar's topic was "Experience Sharing
More
Medicilon Successfully Hosted a CFDA IND Seminar in Seoul, South Korea
Mar 16,2015
Medicilon was interviewed by CCTV NEWS English Channel
CCTV NEWS English Channel launched the special news program, "Free Trade Zone Self-Break and Outlook” during the "Lianghui”, the annual plenary sessions.  As Zhangjiang Hi-Tech
More
Medicilon was interviewed by CCTV NEWS English Channel
Mar 06,2015
Medicilon held Chinese New Year Gala Dinner in USA
On Feb 6, 9 and 12, Medicilon held 3 Chinese New Year & 10th Anniversary Gala Dinners in San Francisco, San Diego and Boston respectively.
More
Medicilon held Chinese New Year Gala Dinner in USA
Feb 06,2015
2015 Shanghai Medicilon Annual Dinner — Work together to get a brighter future
The 2015 Shanghai Medicilon and Medicilon Preclinical Annual Dinner was successfully held on Feb 6.  Medicilon wish you a Happy New Year. On Feb 6,
More
2015 Shanghai Medicilon Annual Dinner — Work together to get a brighter future
Feb 02,2015
Medicilon passed Guangdong FDA review and examination
Medicilon provides different kinds of animal disease models for pharmacology services such as Cancer Xenograft Models, Neurological Disorders Models, Inflammation & Immunological Disease Models and
More
Medicilon passed Guangdong FDA review and examination
Feb 02,2015
Medicilon's in Vitro and in Vivo Pharmacology Test Successfully Passed the Review by China Food and Drug Administration
The Drug Metabolism Professional Committee of 4th Shanghai Pharmacological Societyand the 1st Symposium was held at Zhangjiang campus, Fudan University on January 29.  Dr. Chunlin
More
Medicilon's in Vitro and in Vivo Pharmacology Test Successfully Passed the Review by China Food and Drug Administration
Jan 15,2015
Medicilon congratulated AD16 is officially accepted by CFDA for clinical trial
Recently, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science and South China Center for Innovative Pharmaceuticals' "Class 1.1 piperazine da ketone chemical drugs”
More
Medicilon congratulated AD16 is officially accepted by CFDA for clinical trial
Dec 31,2014
Medicilon wish you a Happy New Year
The year of 2014 is a successful year to Medicilon.  Medicilon would like to take this opportunity to thank you for the support from all
More
Medicilon wish you a Happy New Year
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->